Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer

This study has been completed.
Information provided by (Responsible Party):
Centre Leon Berard Identifier:
First received: December 27, 2006
Last updated: September 25, 2012
Last verified: September 2012